EGEsra Gürkaş

Esra Gürkaş

*This is an algorithmically generated author record based on publicly available information.

Esra Gürkaş has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical and molecular characterization of 148 pediatric neurofibromatosis type 1 patients: a single-center study identifying 14 novel variants

    by Aslı Genç, Yasemin Ünal, Ahmet Cevdet Ceylan, Mustafa Altan, Esra Gürkaş, Derya Özyörük, Esra Kılıç

    Neurofibromatosis Type 1 (NF1) is a common genetic disorder of childhood, characterized by highly variable expressivity. In addition to café-au-lait spots, it shows multisystemic involvement and may cause skeletal abnormalities, tumor predisposition, and neurodevelopmental delay during childhood. This study aims to investigate the clinical and molecular characteristics of pediatric NF1 patients and to explore possible genotype–phenotype correlations. This study retrospectively evaluated the clinical and molecular findings of 148 pediatric NF1 patients, identifying genotype–phenotype correlations through Next-Generation Sequencing (NGS) and multiplex ligation-dependent probe amplification (MLPA) analysis. The mean age at diagnosis was 8.7 years (1 month to 17 years), with a male-to-female ratio of 0.8. Cafe-au-lait spots were the most common finding (99.3%), followed by freckling (46.6%) and Lisch nodules (28.4%). Additional findings included short stature (29.3%), scoliosis (11.4%), neurodevelopmental delay (14.9%), cutaneous neurofibromas (6.8%), plexiform neurofibromas (6.8%), and optic pathway gliomas (6.7%). Magnetic Resonance Imaging revealed T2 hyperintensities in 72.6% of cases. NGS identified NF1 variants in 94.5% of patients, and MLPA detected full-gene deletions in 2 additional cases. With a molecular diagnostic yield of 95.9%, this study identifies 14 novel variants. Conclusion: This study expands the NF1 variant spectrum in children and emphasizes the value of molecular testing for early diagnosis, especially in infants and those with atypical features. Age-stratified clinical data from a large pediatric cohort revealed a potential link between truncating variants and axillary/inguinal freckling. Beyond diagnosis, molecular testing also supports surveillance and genetic counseling, highlighting its clinical utility in managing pediatric NF1. What is Known: • NF1 is a well-known genetic disorder with highly variable expressivity. It shows a wide range of clinical findings, even among patients with the same genetic variant. While some specific genotype–phenotype links have been reported, most NF1 variants do not show clear clinical patterns. Certain features, like café-au-lait macules, appear early in infancy, but others, such as freckling or neurofibromas, often appear later. What is New: • In our pediatric NF1 cohort, axillary/inguinal freckling was found to be significantly more common in patients with truncating variants. For Lisch nodules, cutaneous neurofibromas, tumor presence, and especially T2 hyperintensities, point estimates suggested a non-significant trend toward higher frequencies in the truncating group. This suggests that some features may differ depending on the type of mutation. A total of 14 novel variants in NF1 were identified through NGS.


  • Open Access

    Attitude and Barriers Towards Epilepsy Surgery: A Survey Among Pediatricians and Pediatric Residents in Türkiye

    by Özge Dedeoğlu, Deniz Yılmaz, Didem Ardıçlı, Esra Gürkaş, Ayşegül Neşe Kurt, Ayşe Kartal

    Objective: The aim of this study was to assess knowledge and attitude towards epilepsy surgery among pediatricians and identify the barriers to referral for epilepsy surgery in Türkiye. Material and Methods: There were 21 statements which included the following: (A) knowledge (B) attitude and (C) barriers towards epilepsy surgery. The survey was mailed to 368 pediatricians. Results: Among responders (n=240); 56.6% (n=136) were pediatricians and 44.4% (n=104) were pediatric residents. Three quarters (76 %) of them had experiences in neurology department and 60.1 % of them encountered ≥30 epilepsy patients per month. Most of participants who had no idea whether epilepsy surgery is one of the treatment options were residents (p=0.046). Almost all responders (97.5%) agreed to consult a DRE (Drug Resistant Epilepsy) patient to a pediatric neurologist for medical options. Nearly half of them (43.2%) had no idea about long-term positive cognitive effects. Whereas one-third of participants stated that it is not a safe process; more than half (57%) reported not knowing where and when to refer these patients. Conclusion: An important finding was the apparent lack of inadequate knowledge of long-term benefits and the specificity of epilepsy surgery although most of them had previous experience in neurology department. Besides the lack of epilepsy surgery centers, lack of communication is also a problem in planning the referral of patients.

  • Psychotic attack during the clinical course of megalencephalic leukoencephalopathy with subcortical cysts: a case report

    by Pınar Aydoğan Avşar, Elif Akçay, Esra Gürkaş

    Objectives Van der Knaap disease or megalencephalic leukoencephalopathy with subcortical cysts (MLC), is a slowly progressive neurodegenerative disease with macrocephaly. We present a case of MLC with a confirmed homozygous MLC1 mutation who presented with a psychotic attack at a very young age. Case presentation An 11-year-old girl was admitted to the emergency room with delusions, hallucinations, and irritability. She was diagnosed with MLC at 18 months old. Her psychotic symptoms were improved with the administration of risperidone treatment added to her valproic acid treatment for EEG abnormality. Conclusion In this case study we reported the first episode of a psychotic attack during the clinical course of MLC. This case indicates the possibility that MLC influences the onset of the psychotic attack. Further investigation with more patients is needed to identify the relationship.

  • Open Access

    The First Case of 4H Syndrome with Type 1 Diabetes Mellitus

    by Gonul Buyukyilmaz, Busra Erozan Cavdarlı, Keziban Toksoy Adiguzel, Mehmet Adiguzel, Cigdem Seher Kasapkara, Fatih Gurbuz, Mehmet Boyraz, Esra Gurkas

    4H syndrome is a rare progressive hypomyelinating leukodystrophy. Hypomyelination, hypodontia, and hypogonadotropic hypogonadism are the 3 classic features of 4H syndrome. Biallelic pathogenic variants in POLR3A, POLR3B, POLR1C, and POLR3K gene cause 4H leukodystrophy. Herein, we present clinical features in two siblings with 4H syndrome. The first patient (16 years) presented hypogonadotropic hypogonadism, euthyroid Hashimoto's thyroiditis and type 1 diabetes mellitus. The second patient (13.5 years) showed normal physical, biochemical and hormonal examination at presentation. It was learned that he was followed up for epilepsy between the ages of 6 months and 6 years, his epilepsy medication was discontinued at the age of 6, and he did not have seizure again. T2-weighted magnetic resonance images showed increased signal intensity secondary to hypomyelination at patients. They were subsequently found to have homozygous mutation in the POLR3A gene. 4H syndrome may present with neurological and non-neurological findings in addition to classic features of 4H syndrome. Progressive neurological deterioration may occur and endocrine dysfunction may be progressive. Although multipl endocrine abnormalities associated with this disorder have been reported to date, a case accompanied by type 1 DM has not been seen in the literature. We do not know exactly whether this is coinsidans or the expansion of the phenotype. So that reporting such cases helps to determine the appropriate genotype-phenotype correlation in patients.


  • Corpus callosum thickness: A predictive factor for the first drug efficiency of self-limited epilepsy with centrotemporal spikes (selects)?

    by Özge Dedeoglu, Hilal Altaş, Deniz Yılmaz, Esra Gürkaş, Başak Gülleroğlu, Seçil Ekşioğlu, Neşe Çıtak Kurt


  • Open Access

    Neurological Manifestations of Multisystem Inflammatory Syndrome in Children

    by Deniz Yılmaz, Esra Gürkaş, Ayşegül Neşe Kurt

    Ilk olarak Londra’nın güneydoğusunda bildirilen çocuklarda COVID-19 ile ilişkili multisistem inflamatuar sendromun (MIS-C) nörolojik bulguları baş ağrısı, bilinç değişikliği, aseptik menenjit, ensefalit, nöbet, ataksi ve inme gibi geniş bir nörolojik belirti ve semptom yelpazesine sahiptir. Bu hastalara mümkün olan en kısa sürede tanı koymak ve multidisipliner bir yaklaşımla tedavi etmek önemlidir. Nörolojik semptomları olan ve çoğu nörolojik açıdan düzelme gösteren MIS-C hastalarında taburculuk sonrası takip ile ilgili az sayıda çalışma vardır. MIS-C’ye bağlı gelişmesi olası nörolojik sekelleri belirlemek için uzun vadeli takip gerekmektedir.


  • Open Access

    Frequency of Brain Death in Children and Donation Rate

    by Oktay Perk, Serhan Özcan, Serhat Emeksi̇z, Emel Uyar, Tevfik Çevi̇ri̇ci̇, Esra Gürkaş

    Amaç: Bu çalışmanın amacı, çocuk yoğun bakıma yattıktan sonra beyin ölümü tanısı alan hastaların sıklığını ve donasyon oranını tespit etmekti. Gereç ve Yöntemler: Geriye dönük bir çalışma olarak yapıldı. Otuz iki yataklı Ankara Şehir Hastanesi Çocuk Yoğun Bakım Ünitesi’nde beyin ölümü tanısı konan hastalar hasta formuna kaydedildi. 01.12.2019 ile 01.12.2021 tarihleri arasında beyin ölümü tanısı almış hastalar dahil edildi. Bulgular: Çocuk yoğun bakım ünitesinde (n= 325) ölen hastalar tarandı. Bu ölen hastalardan 17 (%5.2)’sında beyin Ölümü (BÖ) tanısı kondu. Beyin ölümüne neden olan altta yatan hastalıklar, 7 (%42) hastada santral sinir sistemi patolojileri (serebral palsi, meningosel,hidrosefali vb.) olan hastalardı, 5 (%29)’inde kafa travması (trafik kazaları ve düşme gibi nedenler), 5 (%29) hasta kardiyopulmoner arrest sonrası olmasıdır. Tüm hastalara ek test olarak Kranial BT anjiyo uygulandı. Hipernatremi olan 6 (%35) hasta Santral Diyabetus Insipitus (DI) tanısı aldı. BÖ tanısı konan hastalardan sadece biri (%6) donör olmayı kabul etti. Sonuç: Beyin ölümü tanısı daha sık konulmalıdır. Organ bağışı için halk bilgilendirilmelidir. Organ nakli için kamuoyu oluşturulmalıdır.

  • Open Access

    COVID-19 ve Nörolojik Bulgular

    by Esra Gürkaş, Deniz Yılmaz, Ayşegül Neşe Kurt

    Coronavirus disease (COVID-19) caused by a new coronavirus, SARS-CoV-2, , has become a serious health problem throughout the world. Although COVID-19 primarily presents as an acute respiratory tract infection, many neurological findings have also been described in patients. Neurological findings are classified into three groups as central, peripheral nervous system and musculoskeletal system. The most common central nervous system symptom is headache. Encephalitis, encephalopathy, seizures, acute ischemic stroke are also seen. The most common symptoms in the peripheral nervous system are loss of smell and taste. Myalgia, myositis and rhabdomyolysis also can be seen in musculoskeletal system involvement. Awareness of the neurological symptoms by physicians will be beneficial in early diagnosis and treatment of the disease.


  • Evaluation of micronutrient levels in children with cerebral palsy

    by Kursat Bora Carman, Kursad Aydın, Betul Kilic Aydin, Ali Cansu, Meltem Cobanogullari Direk, Selver Durmus, Nihal Olgaç Dündar, Pinar Gencpinar, Serdal Gungor, Esra Gurkas, et al.

    Background: Many studies evaluating the nutritional status of children with cerebral palsy (CP) have focused on energy requirements and protein intake. The present work aimed to assess nutritional status and micronutrient levels of children with (CP). Methods: This multicenter, cross‐sectional and observational study was conducted in 10 different cities in Turkey. Data were available for 398 participants. Anthropometric measurements, feeding mode, nutritional status, and micronutrient levels were evaluated. Results: The study was conducted with 398 participants (303 patients and 95 healthy controls). Statistical analysis showed that according to the Gomez Classification, weight‐for‐age (WFA) revealed malnutrition in 92.6% of children with CP, based on Centers for Disease Control and Prevention percentiles. Measurements of micronutrient levels showed that zinc levels were low in patients, whereas vitamin A levels were low in controls. Phosphorous and manganese levels were significantly lower in malnourished children than in typical children. The results revealed that children consuming enteral nutrition solutions had higher selenium and lower zinc levels than non‐consumers. Conclusions: Malnutrition is not only a protein‐ or calorie‐based problem; micronutrient deficiencies might cause severe health problems. Children with chronic neurological disabilities must be carefully evaluated for these issues. Therefore, nutritional interventions should be adapted to nutrition.


  • Open Access

    Neurologic Manifestations of COVID 19 in Children

    by Esra Gürkaş, Betül Dünya, Özlem Y. Köken, Tuğba B. Demirdağ, Deniz Yilmaz, Hamit Özyürek, Ayşegül N. Ç. Kurt

    Background: The data related to the neurologic manifestations of coronavirus disease 2019 (COVID-19) in children are limited. The frequency of the neurologic manifestations and the risk factors in the development of these symptoms are not clear. Objectives: We aimed to determine the exact frequency of the neurological symptoms in pediatric patients with confirmed COVID-19 and to identify the risk factors for the development of neurological manifestations. Materials and Methods: We included pediatric Covid-19 patients admitted to the Children's Hospital of Ankara City Hospital between March 22 and June 1, 2020. Neurological findings were questioned by interviewing the patients and their families and detailed neurologic examinations were performed within protection measures. Results: A total of 312 pediatric patients with the diagnosis of COVID-19 were enrolled in the study. Sixty-six participants (21.15%) showed neurologic symptoms during COVID-19. Headache was the most common neurologic symptom and present in 14% (n: 44) of the cases. The other neurologic symptoms were myalgia (n: 30, 9.6%), anosmia/hyposmia (n: 6, 1.9%), ageusia (n: 2, 0.6%), and vertigo (n: 1, 0.3%). Neutrophil-to-lymphocyte ratio (NLR) (P = 0.002) and platelet-to-lymphocyte ratio (PLR) (P = 0.001) were significantly elevated in patients with neurological symptoms when compared to the patients without the symptoms. Conclusions: Physicians should be alert to the neurologic involvement of COVID-19 disease in children. NLR and PLR ratios could have a predictive value for the development of neurological manifestations.